Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $26.4 million.

  • GeneDx Holdings' Accumulated Expenses rose 13811.29% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.4 million, marking a year-over-year increase of 13811.29%. This contributed to the annual value of $12.4 million for FY2024, which is 216.77% up from last year.
  • Latest data reveals that GeneDx Holdings reported Accumulated Expenses of $26.4 million as of Q3 2025, which was up 13811.29% from $28.1 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Accumulated Expenses high stood at $28.1 million for Q2 2025, and its period low was $7.3 million during Q2 2024.
  • Moreover, its 5-year median value for Accumulated Expenses was $16.7 million (2023), whereas its average is $18.0 million.
  • As far as peak fluctuations go, GeneDx Holdings' Accumulated Expenses crashed by 5904.24% in 2024, and later surged by 28552.04% in 2025.
  • Over the past 5 years, GeneDx Holdings' Accumulated Expenses (Quarter) stood at $20.1 million in 2021, then increased by 1.02% to $20.3 million in 2022, then crashed by 40.05% to $12.2 million in 2023, then increased by 2.17% to $12.4 million in 2024, then surged by 111.93% to $26.4 million in 2025.
  • Its Accumulated Expenses stands at $26.4 million for Q3 2025, versus $28.1 million for Q2 2025 and $14.0 million for Q1 2025.